摘要
脓毒症是机体受到病原微生物感染引发的全身炎性反应(SIRS),进一步发展可导致严重脓毒症、脓毒性休克和多器官功能障碍综合征(MODS)。多个流行病学统计资料显示,伴有急性器官功能障碍的脓毒症(严重脓毒症)是世界范围内重症监护病房(ICU)患者死亡的第一位原因。
出处
《中国医刊》
CAS
2010年第10期6-11,共6页
Chinese Journal of Medicine
参考文献23
-
1Shapiro NI,Howell M,Talmor D.A blueprint for a sepsis protocol[J].Acad Emerg Med,2005,12(4)∶352-359.
-
2Becchi C,MalyanM,Fabbri LP,et al.Mean platelet volume trend in sepsis:is it a useful parameter[J] ?Minerva Anestesiol,2006,72(9)∶749-756.
-
3Kinasewitz GT,Zein JG,Lee GL,et al.Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis[J].Crit Care Med,2005,33(10)∶2214-2221.
-
4Spapeon HD,Diltoer MW,Nguyen DN,et al.Effects of N-acetylcysteine on micro-albuminuria and organ failure in acute severe sepsis:results of a pilot study[J].Chest,2005,127(4)∶1413-1419.
-
5Palizas F,Dubin A,Regueira T,et al.Gastric tonometry versus cardiac index as resuscitation goals in septic shock:a multicenter,randomized,controlled trial[J].Crit Care.2009,13(2)∶R44.
-
6Fall PJ,Szerlip HM.Lactic acidosis:from sour milk to septic shock[J].J Intensive Care Med,2005,20(5)∶255-271.
-
7Chien JY,Jerng JS,Yu CJ,et al.Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sep sis[J].Crit Care Med,2005,33(8)∶1688-1693.
-
8Luzzani A,Polati E,Dorizzi R,et al.Comparison of procalcitonin and C-reactive protein as markers of sepsis[J].Crit Care Med,2003,31(16)∶1737-1741.
-
9Clec'h C,Fosse JP,Karoubi P,et al.Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock[J].Crit CareMed,2006,34(1)∶102-107.
-
10Simon L,Gauvin F,Amre DK,et al.Serum procalcitonin and C-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis[J].Clin Infect Dis,2004,39(2)∶206-217.
二级参考文献43
-
1Norstrom E A,Tran S,Steen M,et al.Effects of factor Xa and protein S on the individual activated protein C - mediated cleavages of coagulation factor Va [J]. J Biol Chem, 2006,281 (42) : 31486 - 31494.
-
2Taylor F B Jr, Stearns-Kurosawa D J,Kurosawa S, et al. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis [J]. Blood,2000,95(5) : 1680 - 1686.
-
3Li W,Zheng X,Gu J,et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin [J]. J Thromb Haemost,2005,3(7) :1351 - 1359.
-
4Nan B,Lin P,Lumsden A B,et al. Effects of TNF -a and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells [J]. Thromb Res, 2005, 115 (5):417 -426.
-
5Mammen E F,Thomas W R,Seegers W H. Activation of purified prothrombin to autoprothrombin Ⅰ or autoprothrombin Ⅱ (platelet cofactor Ⅲ or autoprothrombin Ⅱ - A) [J]. Thromb Diath Haemorrh,1960,5(5) :218 - 249.
-
6van Veen S Q,Levi M,van Vliet A K,et al. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis [J].Crit Care Med, 2006, 34 (11): 2799 -2805.
-
7Stephenson D A, Toltl L J, Beaudin S,et al. Modulation of monocyte function by activated protein C, a natural anticoagulant[J]. J Immunol, 2008, 177 (4):2115 - 2122.
-
8Brueckmann M,Hoffmann U,De Rossi L,et al. Activated protein C inhibits the release of macrophage inflammatory protein - 1 - alpha from THP - 1 cells and from human monocytes[J]. Cytokine,2004,26 (3):106 - 113.
-
9Sturn D H,Kaneider N C,Feistritzer C,et al. Expression and function of the endothelial protein C receptor in human neutrophils[J]. Blood, 2003, 102 ( 4 ):1499 - 1505.
-
10Joyce D E, Nelson D R, Grinnell B W.Leukocyte and endothelial cell interactions in sepsis:relevance of the protein C pathway [J]. Crit Care Med, 2004, 32(5 Suppl) :S280 - 286.
共引文献34
-
1詹芝娅,方向明.巨噬细胞移动抑制因子与脓毒血症[J].中国医师杂志,2006,8(1):141-142. 被引量:3
-
2杨炯,方国恩,毕建威.高容量血液滤过重建促炎与抗炎平衡在多器官功能障碍防治中的意义[J].东南国防医药,2006,8(6):423-426. 被引量:3
-
3李银平,乔佑杰,武子霞,钱芳芳,姚咏明,于燕,吴瑶.血必净注射液对脓毒症大鼠血栓调节蛋白及内皮蛋白C受体基因表达的影响[J].中国危重病急救医学,2007,19(6):365-368. 被引量:17
-
4李银平,乔佑杰,武子霞,钱芳芳,姚咏明,于燕,吴瑶.血必净注射液对脓毒症大鼠蛋白C及肿瘤坏死因子基因表达的影响[J].中国危重病急救医学,2007,19(8):488-491. 被引量:33
-
5姚咏明,孟海东.进一步认识活化蛋白C在脓毒症治疗中的抗炎作用[J].武警医学,2007,18(11):805-808. 被引量:1
-
6蒋欣,张国华,高瑞利,张宏炜.巨噬细胞移动抑制因子与动脉粥样硬化及其相关疾病[J].国际脑血管病杂志,2007,15(12):931-934.
-
7吴玉生,张道杰,李建军,付崇健.解毒化瘀方对脓毒症大鼠蛋白CmRNA表达及血浆蛋白C活性的影响[J].山东大学学报(医学版),2008,46(4):382-384. 被引量:5
-
8归咏刚,柴艳芬,姚咏明.脓毒症凝血功能紊乱的药物治疗进展[J].中华外科杂志,2009,47(1):62-64. 被引量:5
-
9刘佩友,于小华,李双杰,卞金陵.巨噬细胞移动抑制因子在病毒性心肌炎中的作用及黄芪甲苷干预研究[J].药学服务与研究,2009,9(1):18-21. 被引量:9
-
10李岩(综述),俞康龙(审校).脓毒症中凝血酶-蛋白酶活化受体1—1-磷酸鞘氨醇信号通路的研究进展[J].中国危重病急救医学,2009,21(3):189-191.
同被引文献37
-
1秦德友,康俊玲,程超,周丽英,俸军林,曾爱源.急性脑梗死患者血清IL-6、IL-8、CRP水平变化及临床意义[J].中国医学前沿杂志(电子版),2014,6(3):39-42. 被引量:21
-
2武子霞(综述),李银平,姚咏明(审校).活化蛋白C的生物学活性及其作用机制研究进展[J].中国危重病急救医学,2007,19(3):182-185. 被引量:22
-
3石美鑫.实用外科学[M].北京:人民卫生出版社,2008:100-150.
-
4Azevedo L. Mitochondrial dysfunction during sepsis[J]. Endocr Metab hnmune Disord Drug Targets, 2010,10 (3) : 214-223.
-
5Mishra N,Wang SW,Vachharajani V,et al. Curcumin modulates leukocyte and platelet adhesion in murine sepsis[J]. Mierocirculation, 2010,17(6) :407-416.
-
6Benay C, Chia S, Ferri LE, et al. L-selectin shedding in sepsis limits leukocyte mediated microvascular injury at remote sites [J]. Surgery, 2009,145 (4) : 384-391.
-
7Faber J, Berkhout M, Vos AP, et al. Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses with- in one week in healthy men and women[J]. J Nutr, 2011,14( 1 ) : 964 - 970.
-
8Piccinini AM,Midwood KS.Endogenous control of immunity against infection:tenascin-C regulates TLR4-mediated inflammation via micro RNA-155[J].Cell Rep,2012,2(4):914-926.
-
9Gupta A,Cooper ZA,Tulapurkar ME,et al.Toll-like receptor agonists and febrile range hyperthermia synergize to induce heat shock protein 70 expression and extracellular release[J].J Biol Chem,2013,288(4):2756-2766.
-
10王烁.脓毒症与多器官功能障碍综合征[J].中国临床医生杂志,2009,37(9):27-29. 被引量:4
引证文献3
-
1黄华锋,李新龙,方向明.闭合性腹部外伤继发脓毒症的临床诊断及急救研究[J].中国现代医生,2013,51(30):42-43. 被引量:4
-
2王敏,李林,李建民,赵新华,张世棋,王艳丽.全肠外免疫营养治疗脓毒症患者的临床研究[J].中国临床医生杂志,2014,42(10):67-69. 被引量:4
-
3江磊.脓毒症患者血小板 TLR4 表达变化与血小板活化的关系及对预后的影响研究[J].中国医学前沿杂志(电子版),2015,7(9):76-79. 被引量:2
二级引证文献10
-
1刘巍.腹部外伤患者的急诊治疗分析[J].内蒙古中医药,2014,33(9):29-29. 被引量:1
-
2黎永胜.闭合性腹部外伤患者的院前急救研究[J].中外医学研究,2014,12(17):147-148. 被引量:1
-
3张克明.腹部外伤患者的临床诊治体会[J].中国处方药,2014,12(4):91-91.
-
4林宇捷.以腹部创伤为主严重多发伤的救治体会[J].中国临床医生杂志,2015,43(10):52-53. 被引量:11
-
5李冰清,钱涛.ω-3脂肪酸肠内营养制剂对神经重症患者C反应蛋白和营养代谢的影响[J].河北医科大学学报,2016,37(7):784-788. 被引量:3
-
6王绍红,刘金涛,袁通梅,罗海丽,吴丹,沈锋.CRRT在老年脓毒症患者治疗中的应用效果及其对血清炎性因子水平的影响[J].山东医药,2016,56(42):97-98. 被引量:26
-
7张潇洁,牛战琴.盆腔脓肿的诊治进展[J].中国生育健康杂志,2020,31(5):500-F0004. 被引量:4
-
8冉悦,廖品琥.LRG1、TLR4在脓毒症患者血清中表达水平及临床意义[J].右江民族医学院学报,2022,44(4):482-485. 被引量:2
-
9杨广宇,王璐,王宇,张驰,曾俊,江华,孙明伟.静脉补充Omega-3多不饱和脂肪酸对脓毒症患者临床结局影响的系统评价与荟萃分析[J].中华损伤与修复杂志(电子版),2023,18(2):148-156.
-
10杨清鑫,吕红君,王小博,姜蕾,曾南.基于整合药理学平台的桂枝-白芍药对抗脓毒症的分子机制研究[J].中国中药杂志,2019,44(13):2691-2700. 被引量:16
-
1王峥,刘长山.静脉滴注丙种球蛋白辅治20例婴幼儿肺炎[J].临床荟萃,2002,17(1):39-40.
-
2凌逸洲.静脉丙种球蛋白佐治婴幼儿肺炎50例疗效观察[J].福建医药杂志,2007,29(4):163-163.
-
3冯丽春,黄小兵.小儿病原微生物感染及其病原学探讨[J].广东医学,1996,17(5):325-326.
-
4陈显琴.静注丙种球蛋白辅助治疗婴幼儿肺炎38例的临床观察[J].吉林医学,2006,27(9):1127-1128. 被引量:3
-
5王亚华.4750例呼吸道感染患儿肺炎支原体IgM抗体检测结果分析[J].浙江预防医学,2008,20(5):52-52. 被引量:7
-
6喻华,晏江丽,黄文芳,刘华.儿童腹泻病原微生物的研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(8):533-535. 被引量:14
-
7薛军.中西医结合治疗肺炎支原体的临床体会[J].中国社区医师(医学专业),2011,13(26):77-77. 被引量:1
-
8陈志敏.难治性肺炎支原体肺炎的诊断与药物治疗进展[J].实用儿科临床杂志,2012,27(4):235-237. 被引量:77
-
9张太海.探讨微量元素治疗小儿重型手足口病毒性心肌炎的疗效[J].中国医药指南,2014,12(20):189-190.
-
10邱波,陈新霞,杜鹃.婴儿肝炎综合征104例病原学及合并症分析[J].淮海医药,2015,33(2):152-153. 被引量:4